Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
- PMID: 30209084
- DOI: 10.1136/bjophthalmol-2018-311946
Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Abstract
Background: To assess prevalence and causes of vision impairment in South-east Asia and Oceania regions from 1990 to 2015 and to forecast the figures for 2020.
Methods: Based on a systematic review of medical literature, prevalence of blindness (presenting visual acuity (PVA) <3/60 in the better eye), moderate and severe vision impairment (MSVI; PVA <6/18 but ≥3/60), mild vision impairment (PVA <6/12 but ≥6/18) and near vision impairment (>N5 or N8 in the presence of normal vision) were estimated for 1990, 2010, 2015 and 2020.
Results: The age-standardised prevalence of blindness for all ages and both genders was higher in the Oceania region but lower for MSVI when comparing the subregions. The prevalence of near vision impairment in people≥50 years was 41% (uncertainty interval (UI) 18.8 to 65.9). Comparison of the data for 2015 with 2020 predicts a small increase in the numbers of people affected by blindness, MSVI and mild VI in both subregions. The numbers predicted for near VI in South-east Asia are from 90.68 million in 2015 to 102.88 million in 2020. The main causes of blindness and MSVI in both subregions in 2015 were cataract, uncorrected refractive error, glaucoma, corneal disease and age-related macular degeneration. There was no trachoma in Oceania from 1990 and decreasing prevalence in South-east Asia with elimination predicted by 2020.
Conclusions: In both regions, the main challenges for eye care come from cataract which remains the main cause of blindness with uncorrected refractive error the main cause of MSVI. The trend between 1990 and 2015 is for a lower prevalence of blindness and MSVI in both regions.
Keywords: blindness; epidemiology; global burden of disease study; vision impairment; vision loss expert group.
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: JBJ: Consultant for Mundipharma Co. (Cambridge, UK); Patent holder with Biocompatibles UK Ltd. (Farnham, Surrey, UK) (Title: Treatment of eye diseases using encapsulated cells encoding and secreting neuroprotective factor and/or ant-angiogenic factor; Patent number: 20120263794), and Patent application with University of Heidelberg (Heidelberg, Germany) (Title: Agents for use in the therapeutic or prophylactic treatment of myopia or hyperopia; Europäische Patentanmeldung 15 000 771.4.
Similar articles
-
Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections.Br J Ophthalmol. 2019 Jul;103(7):863-870. doi: 10.1136/bjophthalmol-2018-312068. Epub 2018 Sep 12. Br J Ophthalmol. 2019. PMID: 30209082
-
Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia.Br J Ophthalmol. 2019 Jul;103(7):871-877. doi: 10.1136/bjophthalmol-2018-312292. Epub 2018 Nov 8. Br J Ophthalmol. 2019. PMID: 30409914
-
Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections.Br J Ophthalmol. 2020 May;104(5):616-622. doi: 10.1136/bjophthalmol-2018-313308. Epub 2019 Aug 28. Br J Ophthalmol. 2020. PMID: 31462416
-
Prevalence and causes of vision loss in Southeast Asia and Oceania: 1990-2010.Br J Ophthalmol. 2014 May;98(5):586-91. doi: 10.1136/bjophthalmol-2013-304050. Epub 2014 Jan 9. Br J Ophthalmol. 2014. PMID: 24407561
-
Prevalence and causes of vision loss in sub-Saharan Africa in 2015: magnitude, temporal trends and projections.Br J Ophthalmol. 2020 Dec;104(12):1658-1668. doi: 10.1136/bjophthalmol-2019-315217. Epub 2020 Mar 30. Br J Ophthalmol. 2020. PMID: 32229517
Cited by
-
Prevalence and risk factors for cataracts in the Lao People's Democratic Republic: The Vientiane Eye Study.Indian J Ophthalmol. 2022 May;70(5):1599-1605. doi: 10.4103/ijo.IJO_2137_21. Indian J Ophthalmol. 2022. PMID: 35502034 Free PMC article.
-
Research about eye health and eye health services in Pacific Island Countries and Territories: a scoping review.Lancet Reg Health West Pac. 2024 Jul 27;50:101152. doi: 10.1016/j.lanwpc.2024.101152. eCollection 2024 Sep. Lancet Reg Health West Pac. 2024. PMID: 39161741 Free PMC article.
-
Commentary: Analyzing prevalence and risk factors of cataract: Its importance and effort.Indian J Ophthalmol. 2022 May;70(5):1605. doi: 10.4103/ijo.IJO_467_22. Indian J Ophthalmol. 2022. PMID: 35502035 Free PMC article. No abstract available.
-
The burden, causes, and determinants of blindness and vision impairment in Asia: An analysis of the Global Burden of Disease Study.J Glob Health. 2024 Jun 14;14:04100. doi: 10.7189/jogh.14.04100. J Glob Health. 2024. PMID: 38867671 Free PMC article.
-
Effect of intraocular lens implantation on visual field in glaucoma and comorbid cataracts.Int J Ophthalmol. 2020 Apr 18;13(4):580-586. doi: 10.18240/ijo.2020.04.08. eCollection 2020. Int J Ophthalmol. 2020. PMID: 32399408 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous